European equities traded in the US as American depositary receipts were falling on Thursday morning, down 0.2% to 1,525.94 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by insurer Aegon (AEG) and biopharmaceutical firm DBV Technologies (DBVT), which rose 7.2% and 4.1%, respectively.
They were followed by biotech firm Evaxion (EVAX) and pharmaceutical giant Novo Nordisk (NVO), which added 2.7% and 2.1%.
The decliners from continental Europe were led by biopharmaceutical company Cellectis (CLLS) and steel maker ArcelorMittal (MT), which fell 3.2% and 2.7%, respectively.
From the UK and Ireland, the gainers were led by pharmaceutical companies Adaptimmune Therapeutics (ADAP) and Centessa Pharmaceuticals (CNTA), which rose 5.4% and 1.8%, respectively.
The decliners from the UK and Ireland were led by cryptocurrency miner Argo Blockchain (ARBK), which was down 2.5%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.